ASMB · Assembly Biosciences, Inc.
$32.95
+3.00 (+10.02%)
At close · Aug 14
Market Cap
$670.88M
Shares
20.36M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jason A. Okazaki | Chief Executive Officer and President | $2,482,987 |
| William E. Delaney IV | Chief Scientific Officer | $1,264,904 |
| Anuj Gaggar | M.D., Ph.D. Chief Medical Officer | $1,246,051 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jason A. Okazaki | Chief Executive Officer and President | $1,767,191 |
| William E. Delaney IV | Chief Scientific Officer | $963,467 |
| Nicole S. White | Chief Manufacturing Officer | $827,537 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jason A. Okazaki | Chief Executive Officer and President | $1,373,710 |
| William E. Delaney IV | Chief Scientific Officer | $811,821 |
| Nicole S. White | Chief Manufacturing Officer | $705,512 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jason A. Okazaki | Chief Executive Officer and President | $1,801,214 |
| John G. McHutchison | A.O., M.D. Chief Executive Officer and President | $1,759,202 |
| William E. Delaney IV | Chief Scientific Officer | $1,409,944 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| John G. McHutchison | A.O., M.D. Chief Executive Officer and President | $2,866,354 |
| Jason A. Okazaki | Chief Operating Officer | $1,278,822 |
| William E. Delaney IV | Chief Scientific Officer | $1,024,141 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jason A. Okazaki | Chief Operating Officer | $3,905,018 |
| John G. McHutchison | A.O., M.D. Chief Executive Officer and President | $3,194,563 |
| William E. Delaney IV | Chief Scientific Officer | $2,699,021 |
| Thomas J. Russo | Chief Financial Officer | $1,239,659 |
| Jacqueline S. Papkoff | Senior Vice President, Chief Scientific Officer, Microbiome | $993,830 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| John G. McHutchison | A.O., M.D. Chief Executive Officer and President | $7,007,214 |
| Derek A. Small | Former Chief Executive Officer and President | $3,034,331 |
| Thomas J. Russo | Chief Financial Officer | $2,131,451 |
| Luisa M. Stamm | M.D., Ph.D. Chief Medical Officer | $2,126,472 |
| Jacqueline S. Papkoff | Senior Vice President, Chief Scientific Officer, Microbiome | $1,386,911 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Derek A. Small | Former Chief Executive Officer and President | $4,746,040 |
| Jacqueline S. Papkoff | Senior Vice President, Chief Scientific Officer, Microbiome | $4,510,203 |
Executive changes
Key facts
CIK
1426800
CUSIP
045396207
13F (30d)
95 filings
93 filers
Visit website
Investor relations